S Meller

1.3k total citations
42 papers, 1.0k citations indexed

About

S Meller is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, S Meller has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in S Meller's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (5 papers) and Neuroblastoma Research and Treatments (5 papers). S Meller is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (5 papers) and Neuroblastoma Research and Treatments (5 papers). S Meller collaborates with scholars based in United Kingdom, United States and Poland. S Meller's co-authors include CR Pinkerton, Seema Singhal, C Horton, J Treleaven, Jayesh Mehta, R Powles, M. A. Flower, J T Kemshead, D. M. Ackery and T J McElwain and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

S Meller

40 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Meller United Kingdom 21 370 194 194 176 167 42 1.0k
Kyung Duk Park South Korea 20 223 0.6× 174 0.9× 211 1.1× 199 1.1× 141 0.8× 103 1.2k
John J. Hutter United States 18 129 0.3× 100 0.5× 216 1.1× 110 0.6× 133 0.8× 37 877
Theresa B. Haddy United States 19 220 0.6× 79 0.4× 273 1.4× 243 1.4× 137 0.8× 43 1.1k
M. Horowitz United States 16 269 0.7× 306 1.6× 83 0.4× 244 1.4× 33 0.2× 32 1.2k
Michel van Agthoven Netherlands 18 148 0.4× 202 1.0× 127 0.7× 265 1.5× 52 0.3× 59 1.0k
Jón Kristinsson Netherlands 14 304 0.8× 143 0.7× 400 2.1× 98 0.6× 27 0.2× 23 905
Elliott Perlin United States 17 219 0.6× 126 0.6× 65 0.3× 225 1.3× 33 0.2× 58 912
Julia M. Cruz United States 15 182 0.5× 55 0.3× 95 0.5× 273 1.6× 33 0.2× 36 758
Nasrollah Hakami United States 14 331 0.9× 64 0.3× 209 1.1× 71 0.4× 41 0.2× 28 880
Robert M. Weetman United States 26 107 0.3× 566 2.9× 233 1.2× 175 1.0× 210 1.3× 54 1.8k

Countries citing papers authored by S Meller

Since Specialization
Citations

This map shows the geographic impact of S Meller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Meller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Meller more than expected).

Fields of papers citing papers by S Meller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Meller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Meller. The network helps show where S Meller may publish in the future.

Co-authorship network of co-authors of S Meller

This figure shows the co-authorship network connecting the top 25 collaborators of S Meller. A scholar is included among the top collaborators of S Meller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Meller. S Meller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Treleaven, J, Elaine Gadd, J.-P. Favre, et al.. (2012). Guidelines on obtaining consent for systemic anti-cancer therapy in adults. Hematology. 17(5). 249–254. 3 indexed citations
4.
Singhal, Seema, P. Jean Henslee‐Downey, R Powles, et al.. (2003). Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. Bone Marrow Transplantation. 31(10). 889–895. 13 indexed citations
5.
Kulkarni, S, R Powles, Bhawna Sirohi, et al.. (2003). Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease. Bone Marrow Transplantation. 32(2). 165–170. 33 indexed citations
6.
Singhal, Seema, R Powles, P. Jean Henslee‐Downey, et al.. (2002). Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. Bone Marrow Transplantation. 29(4). 291–295. 25 indexed citations
7.
Kulkarni, S, R Powles, J Treleaven, et al.. (2000). Melphalan/TBI is not more carcinogenic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years. Bone Marrow Transplantation. 25(4). 365–370. 17 indexed citations
8.
Tegeder, Irmgard, Uta Muth‐Selbach, Jörn Lötsch, et al.. (1999). Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clinical Pharmacology & Therapeutics. 65(4). 357–368. 67 indexed citations
9.
Kulkarni, Shashikant, R Powles, Jayesh Mehta, et al.. (1998). Thalidomide in GVHD - S anti-GVHD effect separable from the antiangiogenesis?. Blood. 92(10). 4 indexed citations
10.
Kulkarni, Shashikant, R Powles, Jayesh Mehta, et al.. (1997). Thalidomide is very effective for chronic GVHD but has no activity in acute GVHD.. Blood. 90(10). 1673–1673. 2 indexed citations
11.
Singhal, Seema, R Powles, J Treleaven, et al.. (1997). Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftment. Leukemia. 11(6). 835–838. 8 indexed citations
12.
Nicholson, A.G., Michael L. Rigby, Christopher Lincoln, S Meller, & Cyril Fisher. (1997). Synovial sarcoma of the heart. Histopathology. 30(4). 349–352. 54 indexed citations
13.
Mehta, Jayesh, R Powles, Seema Singhal, et al.. (1997). Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts. Bone Marrow Transplantation. 19(4). 349–355. 26 indexed citations
14.
Powles, R, S Meller, CR Pinkerton, et al.. (1996). Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia.. British Journal of Haematology. 93. 141–141. 1 indexed citations
15.
Ryalls, Michael, Helen Spoudeas, Peter C. Hindmarsh, et al.. (1993). Short-term endocrine consequences of total body irradiation and bone marrow transplantation in children treated for leukemia. Journal of Endocrinology. 136(2). 331–338. 15 indexed citations
16.
Lashford, L. S., Ian Lewis, M. A. Flower, et al.. (1992). Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.. Journal of Clinical Oncology. 10(12). 1889–1896. 111 indexed citations
17.
Charlton‐Perez, Andrew, et al.. (1990). Impact of childhood cancer on return to normal schooling.. BMJ. 301(6744). 169–171. 39 indexed citations
18.
Powles, R, PM Parikh, C. Smith, et al.. (1990). Bone-marrow transplant from father to son and subsequent graft from son to father. The Lancet. 335(8696). 999–1000. 4 indexed citations
19.
Moyes, Judy S., John W. Babich, Richard Carter, et al.. (1989). Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology.. PubMed. 30(4). 474–80. 34 indexed citations
20.
Northfield, T.C., et al.. (1980). Gall-bladder sensitivity to cholecystokinin in patients with gall stones.. BMJ. 280(6208). 143–144. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung Duk Park Breakdown of academic impact, for papers by John J. Hutter Breakdown of academic impact, for papers by Theresa B. Haddy Breakdown of academic impact, for papers by M. Horowitz Breakdown of academic impact, for papers by Michel van Agthoven Breakdown of academic impact, for papers by Jón Kristinsson Breakdown of academic impact, for papers by Elliott Perlin Breakdown of academic impact, for papers by Julia M. Cruz Breakdown of academic impact, for papers by Nasrollah Hakami Breakdown of academic impact, for papers by Robert M. Weetman
Rankless by CCL
2026